Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction Meeting Abstract


Authors: Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Norton, L.; Hudis, C. A.; Dang, C.
Abstract Title: Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
Meeting Title: 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 69
Issue: 2 Suppl.
Meeting Dates: 2008 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2009-01-15
Start Page: 281S
Language: English
ACCESSION: ISI:000262583201270
PROVIDER: wos
DOI: 10.1158/0008-5472.SABCS-4102
Notes: --- - Meeting Abstract: 4102 -- Suppl. S -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patrick Glyn Morris
    116 Morris
  2. Clifford Hudis
    905 Hudis
  3. Larry Norton
    760 Norton
  4. Chau Dang
    273 Dang
  5. Maura N Dickler
    263 Dickler
  6. Richard M Steingart
    175 Steingart
  7. Tiffany A Traina
    253 Traina